The potential bias introduced into COVID-19 vaccine effectiveness studies at primary care level due to the availability of SARS-CoV-2 tests in the general population.
Lanièce Delaunay C, Nunes B, Monge S, de Lange M, Túri G, Machado A, Latorre-Margalef N, Mlinarić I, Lazar M, Botella Rocamora P, Erdwiens A, Sève N, Domegan L, Martínez-Baz I, Hooiveld M, Oroszi B, Guiomar R, Sperk M, Kurečić Filipović S, Pascu C, Linares Dopido JA, Dürrwald R, Rameix-Welti MA, McKenna A, Castilla J, van Hagen C, Knol M, Bacci S, Kaczmarek M, Kissling E; VEBIS Primary Care Vaccine Effectiveness Group.
Lanièce Delaunay C, et al. Among authors: botella rocamora p.
Int J Epidemiol. 2025 Jun 11;54(4):dyaf086. doi: 10.1093/ije/dyaf086.
Int J Epidemiol. 2025.
PMID: 40534212
Free PMC article.